Program

​​​​​​​

​​​​​​

08:00 – 08:30 Welcome Coffee

​

08:30 – 08:45 Opening Remarks

FRANCE

H.E. Christophe Parisot — French Ambassador to Israel

 

ISRAEL

CEO, Clalit Healthcare Services — (TBC)
CEO, Brainsway

​

08:45 – 09:15 Keynotes — France / Israel

FRANCE

Prof. Marion Leboyer — Professor of Psychiatry, Université Paris-Est Créteil; CEO Fondation FondaMental; PEPR Propsy; Director, Translational NeuroPsychiatry laboratory, Inserm U955

“Goal of the Symposium & Presentation of the French Program in Precision Psychiatry PEPR PROPSY”

​

ISRAEL

Dr. Jordan Lewinski — Head of Mental Health Services, Clalit Health Services

​

09:15 – 10:15 PRECISION PSYCHIATRY: PATIENT STRATIFICATION & TARGETED TREATMENTS

Immuno-Psychiatry: Towards New Treatment Targets

Moderator: Prof. Marion Leboyer, Université Paris-Est Créteil; CEO Fondation FondaMental; PEPR Propsy

​

ISRAEL

Prof. Michal Schwartz — Weizmann Institute of Science
“Towards new targets in Immuno-Psychiatry”

​

FRANCE

Prof. Laurent Groc — CNRS, Bordeaux
“Autoimmunity in neuropsychiatry: from molecule to patients”

 

Prof. David Klatzmann — Inserm & IL TOO, Paris
“Autism as a reversible neuroimmune condition: from experimental mouse models to clinical case reports”

​​

10:15 – 10:45 Coffee Break

​​

10:45 – 12:15 New Digital Tools & AI Towards Precision Psychiatry

Moderator: Dr. Eyal Erook — Head of AI Practice, S. Horowitz.

​

ISRAEL

Prof. Noam Shomron — Tel Aviv University
“AI in Genomics”

 

Dr. Orit Goldman — VP Biology, NeuroKaire
“New tools for patient stratification and drug discovery”

​​

FRANCE

Léah Camarat & Andrij Kulakovskyi — Fondation FondaMental
“AI and mental health”

 

Daniel Szeftel — CEO, Semeia
“Telemonitoring in mental health disorders”

​

Dinah Weissmann — CSO, Alcediag
“RNA editing biomarker blood test for the diagnosis of bipolar disorder”

​​

12:15 – 13:30 Lunch

​​

13:30 – 15:00 New Therapeutics Towards Precision Psychiatry

Moderator: Dr. Anna Elgart, Teva Pharmaceuticals

​

ISRAEL

Prof. Amir Krivoy — Geha Mental Health Center · Chair, Israel Society for Biological Psychiatry (ISBP)
“Metabolic Psychiatry – new targets for diagnosis and treatment”

​

Prof. Ilana Gozes — Tel Aviv University
“Novel approaches to autism, from de novo mutated genes to future innovative therapeutics”

 

Elisabeth Kogan — CEO, Syneris
“New targets in psychiatry”

 

Dr. Eran Harary — CMO, Remepy

​

FRANCE/ISRAEL

Prof. Marion Leboyer & Prof. Jonathan Javitt — CEO, NRX Pharmaceuticals

 

Prof. Marion Leboyer & Prof. Mark Weiser — Sheba Medical Center
“New therapies in schizophrenia” - Lancet Schizophrenia Consortium

​​

15:00 – 16:00 Neuromodulation Towards Precision Psychiatry

ISRAEL

Prof. Yair Bar-Haim — Tel Aviv University · Director, National Center for Traumatic Stress and Resilience

“Targeted Neuromodulation of the Hippocampal Network to reduce intrusive memories in PTSD”

​

Prof. Abraham Zangen, Board Director Brainsway. Head of the Brain Stimulation and Behavior Lab and Chair of the Psychology Brain Program at Ben Gurion University of the Negev.

​

FRANCE

Prof. Mircea Polosan — Grenoble Alpes University, Head of the Adult Psychiatry Department – CHU Grenoble Alpes / INSERM – Brain, Behavior and Neuromodulation “DBS in OCD: from brain networks to personalized therapy”

​

Jeremy Bercoff — CEO, Sonomind

“Ultrasound in mental disorders”

​

16:00 – 17:00 PTSD Clinical Excellence: French–Israeli Perspectives on Hospital Psychiatry and the Care Pathway

Moderator: Gila Tolub, CEO ICAR Collective 

​

ISRAEL

Dr. Keren Avirame — Tel Aviv Sourasky Medical Center Prof. Asher Ben-Arieh — Hebrew University

“Peace of Mind platform”

​

FRANCE

Prof. Denis Peschanski — CNRS Dr. Amaury Mengin – Strasbourg University Hospital, Grand Est Regional Psychotrauma Center

“Novelties and challenges in PTSD treatment”

​

17:00 – 18:00 B2B – Building Collaborative Projects per Domain

Immunology · Digital tools & AI · New treatment targets · Neuromodulation

​​

17:00–17:30 Group meetings

​​

17:30–18:00 Restitution of projects per domain

​​

​​

18:00 Conclusion of the Meeting

​​​​

​​​

​

​​

​​